Government of India has reached out to China to restore the supply of the key medical products including ventilators, N95 masks, personal protective equipment (PPE) and vital components required for manufacturing following the surge in their demand amid the rise in coronavirus (COVID-19) cases in the country, reports the data analytics company, GlobalData.
Although the Indian government has recently banned the export of the medical supplies such as ventilators, N95 masks and PPEs from the country to impede the risk of their shortage, the inadequacy will still pose a big challenge for the nation, revealed the company’s research.
According to the study, the Indian ventilators market, which accounted for around 12% of the Asia-Pacific (APAC) ventilators market in 2019, is expected to grow at a compound annual growth rate (CAGR) of 4.8% through 2025.
“Since the supply chain was severely impacted amid the COVID-19 outbreak, restoring supplies with China will reduce some pressure” commented Rohit Anand, Medical Devices Analyst at GlobalData.
Currently, India’s public health spending of the gross domestic product (GDP) is amongst the lowest in the world. India has fewer intensive care beds and ventilators and most of them are based in large cities. Private healthcare facilities are better equipped but expensive and are non-accessible to a majority of the population.
“India will need to encourage makeshift hospitals and isolation units for treating COVID-19 patients as the existing healthcare facilities will not be enough if the number of patients surges in a pattern similar to Europe and the US,” he added.